Drugmakers aim to curb release of antibiotic waste into the environment
New guidelines put forth by a pharmaceutical coalition aim to limit the overexposure to antibiotics that increases resistance – a problem costing a million lives a year across the globe.
By James Paton, bloomberg
A coalition of drugmakers is introducing new standards aimed at curbing the release of antibiotic waste into the environment amid growing concerns over drug resistance that’s been linked to more than a million annual deaths globally.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
EMA publishes new plan to support antibiotic development
For subscribers
